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Abstract: Capsid uncoating is at the crossroads of early steps in HIV-1 replication. In recent years,
the development of novel assays has expanded how HIV-1 uncoating can be studied. In the in situ
uncoating assay, dual fluorescently labelled virus allows for the identification of fused viral cores.
Antibody staining then detects the amount of capsid associated with each viral core at different
times post-infection. Following fixed cell imaging, manual counting can be used to assess the fusion
state and capsid signal for each viral core, but this method can introduce bias with increased time of
analysis. To address these limitations, we developed the Overlap Intensity macro in ImageJ. This
macro automates the detection of viral cores and quantification of overlapping fusion and capsid
signals. We demonstrated the high accuracy of the macro by comparing core detection to manual
methods. Analysis of an in situ uncoating assay further verified the macro by detecting progressive
uncoating as expected. Therefore, this macro improves the accessibility of the in situ uncoating assay
by replacing time-consuming manual methods or the need for expensive data analysis software.
Beyond the described assay, the Overlap Intensity macro includes adjustable settings for use in other
methods requiring quantification of overlapping fluorescent signals.
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1. Introduction
The viral capsid is critical for multiple early steps of HIV-1 replication. The conical
capsid is made of ~1500 monomers of the viral capsid (CA) protein which surrounds
the genomic RNAs and other associated proteins to form the viral core [1,2]. The capsid
is implicated in the protection of the reverse transcription complex (RTC), microtubule
assisted transport, and nucleoporin interactions [3–6]. The disassembly or remodeling
of the capsid, a step termed uncoating, is a requirement for replication with hyperstable
and unstable capsid mutants associated with decreased infectivity [3,7]. Furthermore, the
process of uncoating also has an interplay with reverse transcription and nuclear import of
the viral genome [8–11]. The ability to study the capsid and uncoating has improved due
to recent advancements in the field.
There are multiple assays available to study uncoating including capsid core stability
assays, the fate of the capsid assay, the CsA washout assay, and fluorescence microscopybased uncoating assays [1,3,12–25]. Each of these assays has different strengths and weaknesses, so often a combination of assays is used to study the factors that influence uncoating.
Several uncoating assays have been developed utilizing fluorescence microscopy with capsid detection by antibody staining or through the use of fluorescent markers [8,15–17,19–22].
Collectively, fluorescence microscopy techniques allow the process of uncoating to be studied in infected cells with direct visualization of the capsid and the process of uncoating
relative to other cellular structures or proteins. However, these assays are dependent of
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optimal fluorescent labelling and staining of virus. Some of these fluorescent microscopy
assays may also focus on a bulk population of virions, some of which may be uninfectious.
Most recently, fluorescent microscopy-based uncoating assays have been developed
that utilize live cell imaging to track the progression of early steps of replication (uncoating,
reverse transcription, cytoplasmic transit, nuclear import) in single virions and, in some
assays, infection of the target cell [15–17,22–25]. Despite the importance of these experiments, the equipment needed to maintain live cell imaging can be limiting to research
institutions. A more accessible alternative to live microscopy-based experiments is the in
situ uncoating assay, which relies on fixed cell imaging over a time course [8,19]. The in
situ uncoating assay is a confocal microscopy-based experiment where dual-labelled HIV-1
is used to infect cells. The dual-labelled virus includes either GFP-tagged Vpr or integrase
(IN) viral proteins [18,26,27]. The GFP-tagged proteins associate with the viral core and
act as a marker for its location in the cytoplasm and nucleus of the cell. In addition, the
virus producer cells are transfected with a S15-dTomato plasmid. S15-dTomato includes
the N-terminal segment of c-Src which embeds into the cell membrane [27,28]. As progeny
virions bud from producer cells, the tagged host membrane is incorporated into the HIV
viral membrane. Inclusion of the S15-dTomato into the viral membrane allows fusion to
be tracked with the loss of the dTomato signal. In the in situ uncoating assay, cells are
infected with this dual-labelled virus and then fixed over a time course. Fixed cells undergo
antibody staining for CA with a Cy5-conjugated secondary antibody. The Cy5 signal allows
the extent of uncoating to be quantified by either the percentage of Cy5-positive virus or
the mean maximum Cy5 intensity at different times post infection [19,29]. Since its development, the in situ uncoating assay has been used to examine general uncoating kinetics,
the effects of capsid mutations on uncoating, and the impact of reverse transcription on
uncoating [7,8,11,19,30]. More recently, the in situ uncoating assay has been instrumental
in examining the role of multiple cellular factors (Dynein, Kif5B, FEZ1, BICD2, Nup358,
Dia1, Dia2, EB1, CLIP170) involved with cellular trafficking and nuclear import on uncoating [14,29,31–34]. These findings have been further supported by alternate uncoating
assays or by characterizing related replication steps. Therefore, the in situ uncoating assay
is a valuable tool for revealing different aspects of the early steps of HIV replication.
Following the imaging of fixed cell samples in the in situ uncoating assay, images must
be analyzed to determine the extent of uncoating. First the GFP-positive viral particles
must be sorted into fused (dTomato-negative) and unfused (dTomato-positive) categories.
GFP-positive viral particles that have fused are then measured for Cy5 intensity as the
primary readout of capsid. Typically, the majority of imaged puncta represent unfused
cores resulting in a lower population of fused virus for analysis [8,14,29]. To quantify
a sufficient number of fused viral cores, multiple images are necessary. Increasing the
number of images per sample increases the total viral core count but extends the time of
data analysis. Several approaches can be used for data analysis. One option is to manually
count GFP signals before sorting each virus into fused, unfused, coated, and uncoated
groups. This manual analysis is carried out through the placement of regions of interest
(ROIs) around GFP signals. Total ROIs are counted, followed by visual inspection for
dTomato and Cy5 signal that overlaps with the ROI. While the manual method can be
utilized with a variety of image processing software applications, the analysis proves to be
laborious. Potential bias may also be introduced as a dim GFP signal may be undercounted
or vary between individual counters. In instances where the signal is low or a confocal
system lacks sensitivity, virus detection can be inaccurate and imprecise under visual
inspection. An alternative to manual counting is the use of semi-automatic methods. Semiautomatic analysis requires an established protocol or macro within an image processing
software, but user bias is removed with automatic detection of virus labelling. Rapid
detection and measurement of signal overlap further eliminate the downsides found in
the manual method. Currently no freely available software is designed for detection and
quantification methods specific to the in situ uncoating assay. Software that has been used
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in previous research, such as Imaris and MetaMorph Imaging Software, are capable of
analysis but are limited by the cost for software access [14,29].
ImageJ is a free open source alternative to cost restrictive imaging software [35].
ImageJ includes a flexible toolset for image processing with plugins available to expand
analysis options. Within ImageJ is a set of adaptable tools, including scripting capabilities,
to develop macros and plugins. Building on the ImageJ framework, Fiji Is Just ImageJ
(FIJI) represents a packaged version of ImageJ with the inclusion of various plugins and
tools [36]. The colocalization analysis found in FIJI or ImageJ cannot be used for the in
situ uncoating assay. Colocalization measures the degree of overlap between two signals,
which is often expressed as the Pearson’s correlation coefficient or Manders coefficient.
The output of these analyses does not include a fluorescence intensity for each fluorophore
in an ROI. When using the current capabilities of ImageJ for the in situ uncoating assay,
GFP punctate can be manually counted as ROIs followed by the measurement of dTomato
and Cy5 intensity in each ROI. However, the large number of particles counted contributes
extensive time spent processing images during analysis, as previously described.
In this work, we have developed the semi-automated Overlap Intensity macro for
ImageJ to automatically count GFP signal and then measure dTomato and Cy5 intensity in
each ROI. We validated our macro’s ability to detect GFP signal above background against
a manual counting method. Additionally, we used this macro to analyze data from the
in situ uncoating assay. In developing this macro, we hope to expand the accessibility of
the in situ uncoating assay. Importantly, we have designed the Overlap Intensity macro
with adjustable settings to allow for use beyond the described uncoating experiment. The
Overlap Intensity macro is available for download at https://github.com/HulmeLab/
Overlap-Intensity-Macro (accessed on 11 August 2021).
2. Materials and Methods
2.1. Cell Lines and Pharmaceuticals
The 293T HEK cell line was received from the Hope lab at Northwestern University [8].
293T cells were cultured in Dulbecco’s Modification of Eagle’s Medium (DMEM, Corning),
1% Penicillin/Streptomycin/L-Glutamine (PSG, Corning), and 10% Fetal Bovine Serum
(FBS, R&D Systems, Minneapolis, MN, USA). The human microglial cell line CHME3
was received from the Naghavi lab at Northwestern University [37]. CHME3 cells were
maintained in DMEM with 1% PSG, 5% FBS, and 0.91 mM Sodium Pyruvate (Corning). All
cell lines were maintained at 37 ◦ C with 5% CO2 . Baflomycin A (BafA, Sigma, St. Louis, MO,
USA) was stored at −20 ◦ C and used at a working concentration of 0.02 uM. DEAE Dextran
(Sigma) was used at a concentration of 10 ng/µL and was stored at 4 ◦ C. Polyethyleneimine
(PEI) was aliquoted in sterile ddH2 O and stored at 4 ◦ C.
2.2. Virus Production and Characterization
Dual-labelled VSV g pseudotyped HIV-1 was produced through PEI transfection
of 293T HEK cells with four plasmids as previously described: CMV-VSV-G, HIV-GFP,
GFP-Vpr, and S15-dTomato [27]. The HIV-GFP proviral plasmid has mutations present
in the Env gene to render it replication defective (∆Env, [38]). In this plasmid, GFP is
cloned into the Nef position and functions as a GFP reporter for infection of the cell. For
the imaging experiments described here, the GFP reporter does not impact GFP labelling
when making dual-labelled virus. Virus was harvested by passage of transfected cell media
through a 0.45 um syringe filter (Millex-HV) before storing virus aliquots at −80 ◦ C. Virus
was characterized on glass to confirm GFP co-labelling with dTomato and CA staining
percentage of at least 80% and 50%, respectively. Sterile glass coverslips were transferred to
a 24-well plate before a 15 min treatment with Poly-L-Lysine (Sigma). Dual-labelled virus
was added to the subbed glass coverslips at 3 concentrations (undiluted, 1/10 dilution,
and 1/20 dilution) to determine the concentration used for future experiments. Plated
virus was then centrifuged for 1 h at 1200× g, 16 ◦ C. After centrifugation, all coverslips
were fixed with 4% paraformaldehyde for 15 min. Coverslips were then washed with
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PBS, permeabilized with 0.05% Triton X in PBS for 15 min, and blocked with 10% FBS
solution for 45 min. Primary antibody staining with the human Anti-HIV-1 p24 monoclonal
antibody (241-D) was carried out overnight at 4 ◦ C [39–41]. Secondary antibody stain
was carried out with an anti-human 647 antibody (Jackson ImmunoResearch) at room
temperature for 1 h. Coverslips were mounted onto glass slides using ProLong™ Glass
Antifade Mountant and imaged using confocal microscopy.
2.3. Validation Assays
For virus on glass validation assays, sterile glass coverslips were transferred to a
24-well plate before a 15 min treatment with Poly-L-Lysine (Sigma). For virus on cell
validation assays, glass coverslips stored in 70% ethanol were transferred into 24-well
plates and treated for 30 min with EmbryoMax 0.1% Gelatin (MilliporeSigma) at room
temperature. CHME3 cells were plated at 120,000 cells per well and incubated overnight.
Dual-labelled virus was applied to the coverslips at 1/10th, 1/20th, 1/30th, and 1/40th dilutions in media. Plates were then centrifuged for 1 h at 1200× g, 16 ◦ C. After centrifugation,
all coverslips were immediately fixed with 4% paraformaldehyde for 15 min. Antibody
staining and coverslip mounting were carried out as described in the Virus Production and
Characterization section. Coverslips were imaged using confocal microscopy.
2.4. In Situ Uncoating Assay
Glass coverslips stored in 70% ethanol were transferred into 24-well plates and treated
for 30 min with EmbryoMax 0.1% Gelatin (MilliporeSigma) at room temperature. CHME3
cells were plated at 120,000 cells per well and incubated overnight. Infection was carried
out with a 1/10th dilution of dual-labelled virus with 1X DEAE Dextran. A cell only
condition was included with mock infection to determine cell background. As a fusion
control, one coverslip underwent four hours of infection with constant BafA treatment.
Cells underwent spinoculation for 1 h at 1200× g, 16 ◦ C. Following spinoculation, the
infection media was aspirated with the addition of 37 ◦ C culture media initiating the
infection time course. At each time point, coverslips were fixed with 4% paraformaldehyde
for 15 min. Antibody staining and coverslip mounting were carried out as described in
the Virus Production and Characterization section. An antibody control was included by
staining one infected coverslip with only the secondary antibody. Coverslips were imaged
using confocal microscopy.
2.5. Confocal Microscopy and Image Processing
Fixed coverslips on glass slides were imaged with a Leica SP8 DMI8 confocal microscope using the Leica Application Suite X (LASX) software (Leica Microsystems, Buffalo
Grove, IL, USA). All images were acquired with a pinhole size of 1.00 AU. GFP, dTomato,
and Cy5 signal were sequentially captured with 488 nm, 532 nm, and 635 nm wavelength
lasers. For each experimental condition, 10 images were acquired as a Z-stack. For each
image, the Z-stack was maximum projected into a 2D image. Using the LASX software,
images were then thresholded to remove background in the GFP, dTomato, and Cy5 channels. The background level thresholds were determined for GFP and dTomato according to
the stained cell only control. Cy5 background threshold was set based on the secondary
antibody only negative control. After thresholding for background, images were exported
as TIFFs for analysis in ImageJ.
3. Results
3.1. Establishment of the Overlap Intensity Macro
Upon completing an in situ uncoating assay experiment, the data analysis requires
categorizing and sorting individual viral cores based on labelling. Various combinations of
the three fluorescent labels allow for each virus to be identified as either unfused, fused
with detectable capsid signal, or fused with no detectable capsid signal (Figure 1). Virus is
identified based on GFP-positive punctate marked by GFP-Vpr. The presence of dTomato
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at 79.8% and 68.8% (Table 1). Beyond 1 h post-infection, the percentage of coated virus
decreased at 2 h post-infection before leveling off for the remainder of the time course.
A slight increase in coated virus was detected at 4 h post-infection at 31.1%. The loss
of coated particles over time suggests progressive uncoating as expected from previous
studies [8,11,19].
Table 1. In situ uncoating data from two independent experiments.
Time of Fix
Post-Infection (h)

Count

Average % of
CA-Positive Virus

Mean Max Cy5
Intensity

Average % of
Fusion

BafA
0
1
2
3
4

2028
770
409
114
67
268

61.6
79.8
68.8
32.8
24.3
31.1

46.9
60.5
18.4
8.9
3.5
8.5

16.3
16.3
33.9
18.1
19.1
27.5

Alternatively, the maximum Cy5 signal from each virus can be plotted on a column
scatter plot with a calculated mean (Figure 5C; [14,29]). By accounting for the Cy5 intensity
of each viral core, sensitivity to changes in capsid association are improved. While the
percentage of CA-positive virus provides insight, the use of mean maximum intensity can
identify subtler changes in uncoating. The BafA and 0 h time point were found to have
the highest Cy5 intensities at 46.9 and 60.5, respectively (Figure 5C; Table 1). As infection
progressed, the average Cy5 intensity decreased from 0 to 3 h post-infection (Figure 5C;
Table 1). The decrease in mean maximum intensity suggests that viral cores are uncoating
over time. In addition, the total number of fused cores detected during imaging decreased
with time, which has been previously observed (Figure 5C; Table 1; [8,32]).
Finally, to ensure that variable viral fusion at each time point does not bias these data,
the percentage of viral fusion was calculated as the number of dTomato-negative cores
divided by the total number of GFP -positive signals (Figure 5D; Table 1). For the BafA
and 0 h time point conditions, the extent of viral fusion was 16.3%. We anticipated viral
fusion to be less than 20% for both conditions, which was observed. For the remaining
time points, the fusion percentages spanned from 18.1% to 33.9%, which is consistent with
previous studies (Figure 5D; Table 1; [14,29]).
4. Discussion
The in situ uncoating assay is a well-established assay and has been extensively
used to study HIV-1 uncoating. Unlike other fluorescence microscopy-based uncoating
assays, this assay does not require live cell imaging capabilities. The fixed cell approach
of the assay maintains a high amount of virus for quantification, providing a readout of
capsid state. However, without semi-automated analysis, throughput remains low. Proper
quantification of data first requires identification of ROIs followed by the measurement
of overlapping signal intensities across multiple channels. While previous publications
have utilized semi-automated approaches, these protocols are not freely available or rely
on commercial software [14,29]. Importantly, this analysis is distinct from measuring
colocalization and requires a specific workflow not found in imaging software. Therefore,
we have developed the Overlap Intensity macro for analysis of the in situ uncoating assay
for ImageJ.
During quantification, the primary factor that contributes to the time of analysis is the
detection of each fluorophore above background fluorescence. Manual sorting methods
prove time consuming and are further complicated by weak fluorophore signal. In instances
where dTomato or Cy5 signal is faint, viral cores may be incorrectly categorized as fused
or uncoated by manual inspection. GFP punctate may also be incorrectly excluded due
to low signal intensities. To remove the bias introduced by visual sorting, the Overlap
Intensity macro automates the detection of ROIs and signal intensities. We were able to
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demonstrate the high accuracy of the macro in GFP detection by comparing ROI counts to
a manual approach, both when virus was adhered to glass and bound to cells (Figure 4).
There was more variation in the validation assay conducted on cells, which can be seen in
the wider spread of points between the manual counters and the macro and the lower R2
values (Figure 4B), compared to the assay on glass (Figure 4A). This result is likely due to
the increased and non-uniform background fluorescence associated with cells. At all virus
dilutions, the semi-automated method for GFP detection was highly similar to the manual
counts, indicating comparable accuracy, but by automating the detection process, we have
drastically improved time of analysis.
Next, we utilized the macro to successfully assess the in situ uncoating assay. Over
time, viral cores will uncoat, resulting in a decrease or loss of Cy5 signal. In agreement
with previous work, we found a progressive loss of HIV-1 capsid under two quantifications
(Figure 5B,C; Table 1; [8,11,14,19,29]). When quantifying the percent of CA-positive virus,
a small amount of uncoating was found between the 0 and 1 h timepoints. After 1 h
post-infection, virus rapidly uncoated to less than 40% for the remainder of the time
course (Figure 5B). Analyzing the same data by maximum Cy5 intensity indicated a similar
loss of CA with time (Figure 5C). However, the mean maximum Cy5 intensity decreased
more substantially from 0 to 1 h post-infection. This loss of Cy5 signal indicates that
uncoating was detectable shortly after viral fusion. The early detection of uncoating
shown through Cy5 signal is likely a result of improved sensitivity. By categorizing
virus as simply CA-positive or -negative, differences in CA amounts are lost. In recent
years, quantification of these subtle changes has become increasingly important given
studies showing evidence of biphasic uncoating, uncoating at the nuclear pore, and nuclear
uncoating [6,16,20,23,25,44]. If the imaging system used is appropriately sensitive, the
mean maximum intensity provides a better readout of capsid state. In addition, comparing
the maximum intensity between time points within an experiment minimizes the effect of
suboptimal capsid staining. For this reason, recent studies using the in situ uncoating assay
quantify and compare the maximum intensity over time or among different conditions. For
example, this method has been used to demonstrate the impact of several cellular proteins
involved in cellular trafficking and nuclear import on uncoating [14,29,31–34]. Despite
differences between both methods of analysis, these data demonstrate the Overlap Intensity
macro’s ability to detect uncoating. The CA antibody 241-D was used for these experiments,
which has been previously used in live and fixed cell imaging experiments [24]. While it is
possible that the accessibility of the epitope recognized by this antibody may vary over
time, these results are consistent with previous in situ uncoating assays using different
antibodies to detect CA [8,11,14,19,29,31].
Beyond the loss of Cy5 signal, various controls must be considered. During early
replication, viral fusion precedes uncoating. The in situ uncoating assay typically utilizes
VSV g pseudotyped virus so that viral fusion can be synchronized by spinoculation and
temperature shift. VSV g-mediated viral fusion occurs by endocytosis, which is different
from the canonical entry pathway mediated by HIV-1 Env at the cell membrane. The
kinetics of viral fusion from these two methods have been shown to be different, with
Env-mediated viral fusion having an increased half-life [8]. However, the method of
viral fusion did not impact uncoating kinetics once the different kinetics of viral fusion
were taken into account [8]. In the in situ uncoating assay, viral fusion is measured
by the loss of dTomato signal and only fused virions are assessed for uncoating. To
limit the number of unlabelled virions that could obscure results, dual-labelled virus
stocks must first be verified for dTomato labelling of 80% or more before use. Labelling
verification includes the detergent-based permeabilization step that reduces the native
dTomato labelling during antibody staining. The virus stock used in this work was verified
for proper labelling prior to use (Figure 5A). However, due to the importance of the
dTomato label, reassessment of the BafA and 0 h condition is necessary within each
experiment. The loss of dTomato signal in less than 20% of detectable cores therefore
confirms proper labelling and further strengthens data. Differences in the percentage of
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fused virus could bias the uncoating data by increasing or decreasing the number of fused
cores. Therefore, fusion was tracked by calculating the percent of dTomato-negative cores
relative to the total count. While incomplete dTomato labelling and low signal above
background contribute to some variation, fusion should remain consistent. We were able to
show an acceptable range for percentage of fused virus. The lowest fusion rate was found
to be 16.3% with peak fusion at 33.9% (Figure 5D; Table 1). The range of fusion over time
was 17.6% with an average of 21.9% fused cores. Previous work has shown fusion with
percentages ranging less than 20% [11,14,19,45]. The low variation of fusion suggests that
these differences do not substantially impact our analysis of uncoating. Within these data,
we also observed that less than 20% of total cores were fused for the 0 h post-infection and
BafA treatment conditions (Figure 5D; Table 1).
Previous use of the in situ uncoating assay has reported a progressive loss of fused
viral cores, distinguished as fewer GFP-positive cores over time [8,32]. Here, we were also
able to observe a decrease in the number of fused viral cores (Figure 5C; Table 1). This
loss may be explained by the dissociation of GFP-Vpr from the viral core during viral
replication. Vpr is shed from coated and uncoated RTCs following fusion, which may
further reduce GFP punctate to background levels [46]. Some studies have found that Vpr
assists in the nuclear import of the pre-integration complex (PIC) and can localize to the
nucleus [47–49]. Once nuclear, Vpr may dissociate from the PIC leading to a decreased
number of GFP labelled viral cores at later time points. In this study, we were unable to
differentiate between cytoplasmic and nuclear GFP labelled viral cores due to the absence
of a nuclear envelope marker. Another explanation for the loss of GFP-positive viral
cores may be proteasomal degradation of exposed RTCs. Prior to uncoating, the capsid
protects the internal RTC from detection and degradation [4,6,50,51]. Uncoated cores
are then susceptible to host restriction factors or cell degradation pathways, resulting in
the decreased number of fused viral cores at later time points. An alternative to GFPVpr is GFP-tagged integrase (IN-GFP), which remains with the PIC following nuclear
import [6,26]. However, loss of GFP signal can occur from proteasomal degradation of
IN-GFP and the integration of the viral genome [6,52]. Despite the cause of decreasing
GFP-Vpr, the Overlap Intensity macro was able to detect this previously reported trend.
While we have shown our macro to be accurate with improved time of analysis, any
automated process has caveats. The macro workflow by default utilizes a max entropy
auto-threshold to segment images. The use of a max entropy threshold may not properly
separate objects from the background for all images. Depending on the background and
object intensity, artifacts may be included or objects lost. To accommodate other uses, we
have included the option to select from the 16 included thresholding algorithms in ImageJ.
Furthermore, to detect improper image segmentation, we have included the option to check
an image immediately after thresholding. In doing so, the user can choose to terminate
the process if an image does not appear properly segmented. Another consideration
is that the particle identification relies on the size of the primary fluorophore. If the
secondary fluorophores, dTomato and Cy5, encompass a larger area than GFP, then the
non-overlapping areas are not quantified. This results in some loss of information about
each particle and represents a potential weakness of the macro. However, in maintaining a
stricter ROI, the potential overlap of adjacent virus is excluded. In addition, quantifying
the maximum intensity of Cy5 fluorescence rather than total intensity minimizes the effect
of this weakness. Finally, the macro is capable of quantifying intensity from overlapping
signals but is not capable of colocalization analysis. However, various plugins are available
for use in ImageJ or FIJI to assess colocalization.
In designing this macro, the primary goal was the analysis of the in situ uncoating
assay. However, we have included adjustable settings that allow for use outside of the
uncoating assay. For example, the HIV viral core has been shown to associate with cellular
proteins involved in microtubule trafficking and nuclear import [53]. The Overlap Intensity
macro could be used to assess the amount of a cellular protein associated with the viral
core at different time points or under different cellular conditions. We have shown signal
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detection based on GFP which was identified on a green image channel. In cases where the
signal of interest is not green, we have included the option to select green, red, blue, gray,
cyan, magenta, and yellow channels for ROI identification. User options are expanded
further into selecting which channels to measure overlap intensity. Here, we only measured
red and blue channels, but all channel options are available. Lastly, all required settings to
operate the macro are included or accessible from the user interface. This option includes
shortcuts for adjusting image scale and selecting measurement parameters for intensity
and area. The macro is openly available for download and use in ImageJ and FIJI at
https://github.com/HulmeLab/Overlap-Intensity-Macro (accessed on 11 August 2021).
Therefore, we encourage users to test and apply the Overlap Intensity macro to uses beyond
the in situ uncoating assay.
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